Evidence map›Paper›PMID 32547271›Full record

ArticleRisk management and healthcare policy2020

Drug-Related Problems and Pharmacist Intervention at a General Hospital in the Jazan Region, Saudi Arabia.

Salmeen D Babelghaith, Syed Wajid, Ziyad Alrabiah, Mohammed Abdu M Othiq, Sultan Alghadeer, Abdulaziz Alhossan, Mohamed Al-Arifi, Ibraheem M Attafi

Open access · goldAbstract read
In one paragraph

Article in Risk management and healthcare policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Methicillin-resistantQatar medical journal · 2024
    Article
  8. Article
  9. Patterns of drug-related problems and the services provided to optimize drug therapy in the community pharmacy setting.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Role of pharmacist during COVID-19 pandemic: A retrospective study focused on critically ill COVID-19 patients.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Salmeen D BabelghaithDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Syed WajidDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-4077-4524
Ziyad AlrabiahDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0003-2403-3336
Mohammed Abdu M OthiqMinistry of Health, Sabya General Hospital, General Directorate of Health Affairs, Jazan, Saudi Arabia.
Sultan AlghadeerDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Abdulaziz AlhossanDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0001-5849-6756
Mohamed Al-ArifiDepartment of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Ibraheem M AttafiPoison Control and Medical Forensic Chemistry Center, General Directorate of Health Affairs, Jazan, Saudi Arabia.
King Saud University · SAHera General Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study examined the incidence of drug-related problems (DRPs) in different inpatient departments along with the medical team response to pharmacist's action in addressing DRPs at Jazan Hospital, Saudi Arabia. PATIENTS AND

methodsThis retrospective study was conducted among inpatients at Ministry of Health hospital in Jazan, a region in southwestern Saudi Arabia. We collected data for a 2-year period (from 2016 to 2017). For any detected DRP of the ordered medications for dispensing, the inpatient pharmacist is sending report for that particular DRP with recommendation to the medical team which in turn might accept or reject such recommendation. Serious drug-drug interactions, as part of DRP, were assessed by utilizing three different online DDI checkers, including Lexi-Comp, Medscape, and Drugs.com.

resultsThe most common type of DRP was serious drug-drug interactions (49%). Over the study period, most incidences of DRPs were decreased. Of the DRPs in 2016 and 2017, antibiotics were the most commonly involved (51% and 69.5%) of cases, respectively, followed by proton pump inhibitors (25.3% and 14.1%) and statins (12.9% and 9.4%). Interestingly, of the 241 interventions for DRPs in 2016, 199 (82.5%) were accepted, resulting in a change in drug therapy (p=0.006). In 2017, 90 (70.3%) interventions out of 128 were accepted by the physician and the drug therapy changed (p=0.029).

conclusionPharmacist interventions appear to decrease the incidence of DRPs, which emphasize the importance of an optimal pharmaceutical care plan for clinical care settings.

Indexed as

drug-related problemsinpatient unitsJazanpharmacist interventionSaudi ArabiaSaudi general hospital

Identifiers

PMID32547271
PMCPMC7237765
OpenAlexW3023872179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.